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1 
 Summary  
 
Nowadays, it is found that more and more diseases can’t be cured by modern 
medicine independently. The advantages of Kampo medicines are recognized 
again. As one kind of Kampo medicines, Kampo decoction plays an important 
role in clinical practice especially in individualized treatment, while the 
inconvenience and time-consuming decocting process make it difficult to be 
used widely in Japan. It is quit necessary to improve the decocting method to 
make more patients accept and benefit from Kampo decoction and 
individualized treatment.  
In this study, we improved the decocting method by using a microwave oven. 
To validate the availability and safety of this new method, we decocted 
Kakkonto (Gegentang in Chinese) that is used mostly in clinical treatment in 
Japan and Keishikabushito (Guizhijiafuzitang in Chinese) that contains a toxic 
herbal medicine-Processed Aconite Root with a microwave oven. To quantify 
the 8 characteristic components in Kakkonto, we developed and validated a 
simultaneous quantitative HPLC-DAD method. And then, regarding the content 
of 8 characteristic components in Kakkonto decoction and 6 toxic components 
in Keishikabushito as indices, the extraction effect and detoxification effect of 
the conventional decocting method as goals which the new decocting method 
should achieve, we optimized decocting conditions of the new method for the 
two formulas with Response Surface Methods respectively. With this new 
method, 35 min was cost for Kakkonto to get almost the same extraction effect 
to the conventional decocting method which cost 40 min; and 45 min was cost 
for Keishikabushito to get almost the same detoxification effect to the 
2 
conventional decocting method which cost 60 min. 
In conclusion, decocting Kampo medicines with a microwave oven is as 
available and safe as with the conventional decocting method. It is convenient, 
efficient, safe, time-saving, electric energy-saving, and may be applied widely in 
clinical treatment. In that case, more patients will benefit from Kampo decoction 
and individualized treatment. 
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1. Backgrounds 
 
Traditional medicine has a long history. In ancient times, it was used to 
diagnose and treat diseases. With the development of science, modern medicine 
developed rapidly and became main medical system. However, it is found that 
more and more diseases were difficult to be cured by modern medicine 
independently. Moreover, nowadays, rapid pace of life, high stress and bad life 
habits induce unbalance of health, a lot of people are in sub-health conditions. 
Modern medicine has no good solution against these. In this instance, merits of 
Kampo medicine are recognized again.  
One of the characters of traditional medicine is to consider the human body as 
a whole. When a person is ill, doctor doesn’t treat the sick part only, but also 
treat correlative parts and enhance immunity of the whole body. Traditional 
medicine can not only treat diseases, but also be good at keeping balance of 
health, enhancing immunity and preventing diseases.   
  Kampo medicines come from plants, animals and minerals. Most of them 
have mild effects. Medicines which have strong effects or contain toxic 
components are usually processed to alleviate effects or toxicity before use. 
They can be used for persons who can’t afford the strong effects of western 
medicines, such as children, the aged and weak patients.  
For above all, more and more doctors and patients pay attention to Kampo 
medicines again in Japan. According to the investigation in 2012, 83.8% of 
doctors prescribed Kampo medicines to patients in Japan, and about 70% of 
these doctors considered Kampo medicines had good effects[1]. 
 
6 
2. Problems 
  
There are 2 major kinds of Kampo medicines in Japan. One is Kampo extract, 
the other is Kampo decoction. Kampo extract was processed in factory before 
sale, so patients don’t need to decoct them; the extract can be stored for several 
years while the Kampo decoction can be kept for about 1 week in cold storage; 
and Kampo extract is convenient to carry. Therefore, Kampo extract is used 
widely in Japan. However, the composition of patent medicines has been fixed, 
it can never be changed. So the treatment range of extract is narrow. Conversely, 
the composition of decoction can be changed to fit the disease. Doctors can 
change the composition to form the most suitable prescriptions to different 
patients. So decoction can be used in individualized treatment; also, because of 
the variability, the treatment range of decoction is much wider. Therefore, the 
application of Kampo decoction should be extended. 
The problem which makes Kampo decoction difficult to be used widely is the 
complex decocting process. It usually cost a long time, 30-60 min daily. If 
patients decoct Kampo medicines with gas, the regulation of fire is difficult, it 
needs some experiences, and patients have to take care of the fire to avoid an 
accident. Of course, patients can buy an electric decocting device with which 
they can decoct Kampo safely, but it costs about 20 000 yen which is much 
more expensive than Kampo medicines themselves. Thus, a long decocting time 
and inconvenient process are the biggest problems for wide application of 
Kampo decoction. Improvement of the decocting method for Kampo medicines 
is quit necessary. 
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3. Previous researches 
 
Recently, microwave technology attracts researchers’ attention. Microwave 
acts on polar molecules, such as water. The heat energy comes from intense 
impact among polar molecules. Thus, it can heat things uniformly, rather than 
from outside to inside. Microwave has a higher heating efficiency, and it takes 
less time than using traditional heating methods. 
Microwave technology has been applied to extraction, processing, desiccation 
and sterilization of crude drugs[2-4]. In extraction studies of crude drugs, the 
researchers obtained higher yield by using microwave than using traditional 
methods[5-6].  
In a word, microwave is an efficient heating source.  
  
4. Objective of this study 
 
In this study, we tried to decoct Kampo medicines with a microwave oven. A 
microwave oven is a widely used (97.5%[7]) kitchenware in Japan. With this new 
method, patients can decoct Kampo medicines safely and don’t need to buy a 
special decocting device only for Kampo medicines. And we also hope it will 
consume less decocting time because of the high heating efficiency of 
microwave. 
We decocted Kakkonto which is the most prescribed formula in clinical 
treatment in Japan[1] with a microwave oven and quantified 8 characteristic 
components to validate the availability of this new method. And, we decocted 
Keishikabushito which contains a toxic crude drug-Processed Aconite Root and 
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quantified 6 toxic components to validate the safety of this new method. Also, we 
found out the optimal decocting conditions under which we can get almost the 
same extraction effect and detoxification effect to the conventional decocting 
method. 
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1. Introduction 
 
In this part, we chose Kakkonto as a representative formula to study the 
availability of decocting Kampo medicines with a microwave oven.  
Kakkonto, a traditional medicinal formula, was first recorded in Shanghan 
Lun, a traditional Chinese medicinal treatise on exogenous febrile diseases 
authored by Zhongjing Zhang during the late Eastern Han Dynasty. It has been 
used since ancient times in Asian countries as a typical medicinal formula to 
treat common colds and influenza. Modern pharmacological studies indicated 
that Kakkonto could inhibit the replication of influenza virus[8], augment the 
level of interleukin (IL)-12 in the early phase of infection[9], and suppress 
responsive IL-1α production subsequent to interferon (IFN) production after the 
infection[10]; these effects consequently result in the alleviation of symptoms 
such as the fever, headache, muscle pain and neuralgia. In addition, Kakkonto is 
also effective for allergic diarrhea[11], chronic urticaria[12], pustular psoriasis[12], 
chronic tension headache[13] and aqueous flare elevation after a cataract 
surgery[14-15]. Nowadays, it is still used conventionally; it is the most prescribed 
formula in clinical treatment[1], and more than 20 million doses are prescribed 
annually in Japan[16].  
In this section, we developed and validated a new simultaneous quantitative 
HPLC-DAD method for 8 characteristic components in Kakkonto decoction. 
And then, regarding content of the 8 characteristic components as the index, we 
optimized decocting conditions with Response Surface Methods (RSMs) and 
found out the decocting conditions under which we can get almost the same 
extraction effect to the conventional decocting method. 
12 
2. Development and validation of an HPLC-DAD method for the 
simultaneous quantification of 8 characteristic components in Kakkonto 
decoction 
 
2.1  Introduction 
 
In previous studies, researchers usually focused on the pharmacological effects 
and mechanisms of Kakkonto. However, the presence of major characteristic 
molecules forms the material basis of efficacy, and usually efficacy has a 
dependency relationship with the content of those molecules. Thus, the 
quantitative analysis of major characteristic molecules in Kakkonto, a commonly 
used traditional medicinal formula, is also important, essential and basic study 
for efficacy studies; and it can provide some information for the correct clinical 
application of Kakkonto.  
 
Kakkonto is composed of 7 crude drugs. The complex composition of the 
traditional medicinal formula makes the quantitative analysis difficult. There 
were limited studies that regarded the quantification of components in Kakkonto. 
In Japanese Pharmacopoeia (16th edition), ephedrine and pseudoephedrine in 
Kakkonto extract are quantified with one HPLC-UV method, while paeoniflorin 
and glycyrrhizic acid are quantified with two other HPLC-UV methods. Other 
papers reported an HPLC-DAD method[17] and a micellar electrokinetic 
chromatography method[18] for the quantitative analysis of the components 
extracted from Kakkonto granules. Okamura analyzed the non-alkaloid 
components in Kakkonto decoction with an HPLC-DAD method[19], and 
13 
analyzed the alkaloid components with another HPLC-UV method[20]. So far, 
there was no report about a simultaneous analysis method for the main alkaloid 
and main non-alkaloid components in Kakkonto decoction. 
 
Moreover, traditional medicines usually contain a great variety of components. 
To decrease the number of components present in the sample injected into an 
HPLC system and to obtain a good separation on a column, sample preparation 
is generally complex. Usually, extraction using some kinds of organic solvent 
has to be done before injection. It will consume some time and may result in 
loss of target components. 
 
In the present study, we established a reliable and efficient HPLC-DAD 
method for the simultaneous quantification of 8 major characteristic components 
in Kakkonto decoction: ephedrine, pseudoephedrine, paeoniflorin, puerarin, 
glycyrrhizic acid, cinnamic acid, cinnamaldehyde and 6-gingerol.  
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2.2 Materials and Methods 
 
2.2.1 Materials 
 
Crude drugs: Pueraria Root (Pueraria lobata Ohwi), Ephedra Herb (Ephedra 
sinica Stapf), Jujube (Zizyphus jujube Miller var. inermis Rehder), Cinnamon 
Bark (Cinnamomum cassia Blume), Peony Root (Paeonia lactiflora Pallas), 
Glycyrrhiza (Glycyrrhiza uralensis Fisher), Ginger (Zingiber officinale Roscoe) 
and Apricot Kernel (Prunus armeniaca L., P. armeniaca L. var. ansu Maxim., P. 
sibirica L.). 
 
Kakkonto is composed of 7 crude drugs. The prescriptions (daily dose) and 
lot numbers are as follows: 
Prescription 1[21]: Pueraria Root 4 g, Ephedra Herb 3 g, Jujube 3 g, Cinnamon 
Bark 2 g, Peony Root 2 g, Glycyrrhiza 2 g, Ginger 2 g. 
Prescription 2[21]: Pueraria Root 8 g, Ephedra Herb 4 g, Jujube 4 g, Cinnamon 
Bark 3 g, Peony Root 3 g, Glycyrrhiza 2 g, Ginger 1 g.  
Lot A: Pueraria Root (Lot No. 001711004), Ephedra Herb (Lot No. 
011711002), Jujube (Lot No. 007111015), Cinnamon Bark (Lot No. 002811022), 
Peony Root (Lot No. 005311009), Glycyrrhiza (Lot No. 002011005) and Ginger 
(Lot No. 005811002) were purchased from Tochimoto Tenkaido (Osaka, Japan). 
Lot B: Pueraria Root (Lot No. 001710005), Ephedra Herb (Lot No. 
01171103), Jujube (Lot No. 007112021), Cinnamon Bark (Lot No. 002810007), 
Peony Root (Lot No. 005310016) and Glycyrrhiza (Lot No. 002007019) were 
purchased from Tochimoto Tenkaido (Osaka, Japan), and Ginger (Lot No. 
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7B00227) was purchased from Uchida Wakanyaku (Tokyo, Japan). 
Lot C: Pueraria Root (Lot No. 001710002), Ephedra Herb (Lot No. 
011710004), Jujube (Lot No. 007111013), Cinnamon Bark (Lot No. 002809018), 
Peony Root (Lot No. 005309015), Glycyrrhiza (Lot No. 002011023) and Ginger 
(Lot No. 005812002) were purchased from Tochimoto Tenkaido (Osaka, Japan). 
 
Maoto (daily dose) is composed of 4 crude drugs: Apricot Kernel 5 g, 
Ephedra Herb 5 g, Cinnamon Bark 4 g, Glycyrrhiza 1.5 g. They were purchased 
from Tochimoto Tenkaido (Osaka, Japan) and lot numbers are as follows: 
Lot D: Apricot Kernel (Lot No. 002512002), Ephedra Herb (Lot No. 
011711002), Cinnamon Bark (Lot No. 002811022), Glycyrrhiza (Lot No. 
002011005). 
Lot E: Apricot Kernel (Lot No. 002512002), Ephedra Herb (Lot No. 
01171103), Cinnamon Bark (Lot No. 002810007), Glycyrrhiza (Lot No. 
002007019). 
Lot F: Apricot Kernel (Lot No. 002512002), Ephedra Herb (Lot No. 
011710004), Cinnamon Bark (Lot No. 002809018), Glycyrrhiza (Lot No. 
002011023). 
 
The standard compounds paeoniflorin, puerarin, glycyrrhizic acid, cinnamic 
acid, cinnamaldehyde and 6-gingerol were purchased from Wako Pure 
Chemical Industries, Ltd. (Tokyo, Japan). The standard compounds ephedrine 
hydrochloride and pseudoephedrine hydrochloride were purchased from Zelang 
(China). Acetonitrile (HPLC grade) was from Sigma-Aldrich (Tokyo, Japan). 
Methanol (HPLC grade) and phosphoric acid were from Wako. Distilled water 
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was prepared by the purification system of Millipore. Tap water (pH 7.2, Ca2+: 
24.7 mg/L, Mg2+: 6.3 mg/L, measured with a polarized Zeeman atomic 
absorption spectrometer, Z-5300, Hitachi, Japan) was used to prepare decoction. 
 
2.2.2 Instruments and chromatographic conditions 
 
Kakkonto was decocted with an HMJ3-1000W electric decocting device 
(domestic Kampo decocting device composed of electric heater and glass 
container, Hario Glass, Japan).  
 
The analysis was performed on an HPLC system (Shimadzu, Japan) 
composed of an LC20AD liquid chromatograph, SPD-M20A diode array 
detector (DAD), CTO-10ASvp column oven and CBM-20A communications 
bus module. The separation was achieved on a Zorbax Extend-C18 column (250 
mm × 4.6 mm i.d., 5 μm, Agilent, USA) at 25°C by 1 ml/min mobile phase 
composed of A-phosphoric acid aqueous solution (pH 2.0, 15 mM) and 
B-acetonitrile. The gradient elution conditions are as follows (shown as the 
percentage of B) : 0-5 min 5%, 5-13 min 5-7%, 13-21 min 7-11%, 21-33 min 
11%, 33-50 min 11-28%, 50-59 min 28-30%, 59-83 min 30-46%. The injection 
volume was 5 μl. The signals were collected at 205 nm for ephedrine and 
pseudoephedrine, 232 nm for paeoniflorin, 250 nm for puerarin and glycyrrhizic 
acid, and 280 nm for cinnamic acid, cinnamaldehyde and 6-gingerol. Detector 
parameters are as follows: lamp-D2, start wave length-190 nm, end wave 
length-400 nm, cell temperature-40°C, and slit width-1.2 nm (high resolution 
mode). The data processing was achieved by LC solution software (Shimadzu, 
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Japan). 
 
2.2.3 Preparation of standard solutions 
 
A stock solution of standard was prepared by accurately weighing the 
standard compounds ephedrine hydrochloride, pseudoephedrine hydrochloride, 
paeoniflorin, puerarin, glycyrrhizic acid, cinnamic acid, cinnamaldehyde and 
6-gingerol, and dissolving them in one volumetric flask with methanol to the 
volume. The final concentrations of the 8 standard compounds in the stock 
solution are 0.15 mg/ml, 0.065 mg/ml, 0.4032 mg/ml, 0.9 mg/ml, 0.39 mg/ml, 
0.025 mg/ml, 0.1616 μl/ml and 0.042 mg/ml, respectively. The standard 
solutions used in this study were diluted from the stock solution of standard with 
methanol and filtrated through a 0.45 μm syringe membrane filter before 
injection. 
 
2.2.4 Preparation of Kampo decoction samples 
 
The daily dose of Kampo formula was decocted with the electric decocting 
device in 500 ml tap water at 600 W for 40 min followed by the filtration 
through gauze. The volume of decoction was adjusted to 500 ml with tap water 
after cooling down to room temperature. The decoction was then filtrated 
through a filter paper under reduced pressure; the subsequent filtrate was 
retained and filtrated through a 0.45 μm syringe membrane filter before 
injection. 
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2.3  Results 
 
2.3.1 Optimization of chromatographic conditions 
 
The main purpose to develop this chromatographic method was to achieve a 
good separation of the 8 components within appropriate time. The type of 
column, composition and pH of the mobile phase, column temperature and 
gradient elution conditions were investigated; the resolution, tailing factor, 
oretical plate number and capacity factor were considered. 
 
The analysis on a C18 column showed a better resolution than that on a 
phenyl column. The peaks of paeoniflorin, puerarin and 6-gingerol could not be 
completely separated from neighboring peaks when the analysis was operated 
on a phenyl column. Phosphoric acid aqueous solution-acetonitrile and 
trifluoroacetic acid (TFA) aqueous solution-acetonitrile were tested as mobile 
phases. The latter showed a serious baseline drift, and the resolution was worse 
than the former. The pH of the mobile phase was tested between 2 and 6. With 
the pH increase of the mobile phase the retention time of ephedrine and 
pseudoephedrine was prolonged so that they co-eluted with the following 
component. Analyses were done at column temperatures of 25, 30 and 40°C. 
With the increase of column temperature the retention time was shortened but 
no good resolution was obtained. The wavelengths were determined at the 
relative strong absorption wavelengths where good resolution can be obtained. 
The absorption of 6-gingerol at 205 nm is stronger than that at 280 nm, but the 
resolution of 6-gingerol and the following peak was not good enough at 205 nm. 
19 
However, at 280 nm, the peak following 6-gingerol has no absorption, so we 
chose 280 nm for 6-gingerol. After repeated trials of varying gradient elution 
conditions, the chromatographic conditions were optimized as described in 
“2.2.2” in this chapter. The typical chromatograms of a standard solution and a 
Kakkonto decoction sample are shown in Fig. 1. 
 
2.3.2 Validation of the chromatographic method 
 
(1) Linearity, range, limit of detection (LOD) and limit of quantification 
(LOQ) 
The calibration standard solutions were prepared by serially diluting the stock 
solution to six concentrations. Peak areas versus component concentrations were 
treated by the least square method. The analytical range was established by the 
highest and lowest concentrations of the six concentrations. LOD and LOQ 
were based on 3.3:1 and 10:1 of the signal-to-noise ratio (S/N), respectively 
(Table 1). 
 
(2) Precision 
The precision of this method was evaluated by the study of intra-day 
precision and inter-day precision. The intra-day precision was evaluated by 
analyses of six replicate samples of standard solutions within one day. The 
inter-day precision was evaluated by analyzing the same standard solution once 
a day for three successive days. The RSDs of peak areas represented in Table 1 
showed a good precision of this method. 
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(3) Accuracy 
The accuracy of this method was evaluated by analyzing the decoction spiked 
with standard compounds in triplicate on three spiked concentration levels. The 3 
levels were chosen according to the general accuracy assay method to make the 
ratios of each component between original decoction sample and spiked standard 
as 1:0.5, 1:1 and 1:1.5. Triplicate 3 ml of decoction sample were put into three 5 
ml volumetric flasks, then, 0.3 ml, 0.6 ml and 0.9 ml of stock solution of standard 
were spiked, respectively, then add methanol to the volume. The percentage of 
recovery for each component was calculated on each level (Table 2). 
 
(4) Specificity 
The specificity of this method was insured by comparing the retention time 
and spectrum of each component in the standard solution with those in the 
sample solutions. The chromatograms of the decoction samples plus standards, 
used in recovery study were also used to monitor purity of the peaks. The 
spectral purity of target peaks was assayed by the diode array detector to 
exclude potential co-elution. 
 
(5) Stability 
The stability of sample solutions was investigated by sequential analyses of 
Kakkonto decoction samples which were put into capped glass bottles and kept 
at both room temperature and 4°C from 0 to 48 hours, respectively. The sample 
kept at room temperature was stable within 8 hours, the data of 24 hours showed 
that cinnamaldehyde volatilized considerably. The sample kept at 4°C was 
stable for 48 hours.  
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2.3.3 Application of this quantitative analytical method 
 
The present method was applied to Kakkonto decoction decocted with the 
conventional decocting method (mentioned in 2.2.4 in this chapter). Moreover, 
Maoto contains some of same crude drugs with Kakkonto; those components 
were also quantified by this method. The analytical data are shown in Table 3.
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Fig. 1  Typical chromatograms of a standard solution and a Kakkonto decoction sample 
A: Chromatogram of a standard solution, B: Chromatogram of a Kakkonto decoction sample 
1: Ephedrine, 2: Pseudoephedrine, 3: Paeoniflorin, 4: Puerarin, 5: Glycyrrhizic acid,  
6: Cinnamic acid, 7: Cinnamaldehyde, 8: 6-Gingerol 
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Table 1  Calibration curve, range, LOD, LOQ and precision of the HPLC method 
 
 
x: Concentration (mg/ml, the unit of cinnamaldehyde is μl/ml), y: Peak area 
a: nl/ml
Components Curve equation 
Range 
(μg/ml) R
2 
LOD 
(ng/ml) 
LOQ 
(ng/ml) 
Precision (RSD (%)) 
intra-day inter-day 
Ephedrine y=11781270x-1972 7.50-90.00 0.9999 9 27 1.41 0.54 
Pseudoephedrine y=12611040x-3570 3.25-39.00 0.9998 8 25 1.27 0.91 
Paeoniflorin y=6442875x-4703 20.16-241.92 0.9999 13 40 1.69 0.59 
Puerarin y=21895340x-1232 45.00-540.00 0.9999 4 12 1.46 0.59 
Glycyrrhizic acid y=4266588x-6261 19.50-234.00 0.9999 20 60 1.59 1.44 
Cinnamic acid y=45627690x-2844 1.25-15.00 0.9999 2 5 1.45 0.53 
Cinnamaldehyde y=54316510x+8770 8.08-96.96 a 0.9999 0.0015a 0.0044 a 1.65 0.48 
6-Gingerol y=3089379x+231 2.10-25.20 0.9999 26 78 1.72 2.00 
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Table 2  Recovery of the 8 components in Kakkonto decoction by the HPLC method 
 
a: mean±S.D., n=3 
b: nl/ml
Components Level 
Amount added
(μg/ml) 
Amount found (μg/ml) Recovery 
 (%) 
RSD 
(%) 1 2 3 
Ephedrine 1 9 9.15 8.97 9.09 100.78±1.02a 1.01 
2 18 18.21 18.15 18.53 99.67±1.12 1.10 
3 27 27.65 27.29 27.24 101.44±0.82 0.81 
Pseudoephedrine 1 3.9 3.92 3.81 3.87 99.10±1.35 1.36 
2 7.8 7.71 7.86 7.79 99.81±0.96 0.96 
3 11.7 11.46 11.66 11.51 98.63±0.87 0.81 
Paeoniflorin 1 24.19 23.41 23.38 23.73 97.17±0.79 1.14 
2 48.38 46.48 48.20 47.65 98.06±1.82 1.86 
3 72.58 71.35 70.27 71.06 97.68±0.77 0.79 
Puerarin 1 54 54.03 53.76 55.07 100.53±1.28 1.27 
2 108 108.90 109.17 109.88 101.22±0.47 0.46 
3 162 162.23 163.29 164.90 100.91±0.83 0.82 
Glycyrrhizic acid 1 23.40 23.54 23.73 23.96 101.45±0.90 0.89 
2 46.80 46.88 47.96 48.26 101.91±1.55 1.52 
3 70.20 71.60 71.66 71.84 102.31±0.18 0.17 
Cinnamic acid 1 1.5 1.49 1.46 1.47 98.00±1.00 1.02 
2 3.0 2.99 3.08 2.96 100.17±2.08 2.08 
3 4.5 4.43 4.49 4.50 99.33±0.88 0.89 
Cinnamaldehyde 1 9.70b 9.76b 9.85b 9.89b 101.39±0.71 0.70 
2 19.39b 19.33b 19.56b 20.05b 101.31±1.90 1.87 
3 29.09b 29.58b 29.60b 29.46b 101.58±0.25 0.25 
6-Gingerol 1 2.52 2.57 2.61 2.61 102.98±1.03 1.00 
2 5.04 5.19 5.22 5.12 102.68±1.07 1.05 
3 7.56 7.86 7.74 7.91 103.64±1.13 1.09 
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   Table 3  Quantification of the 8 characteristic components in Kakkonto decoction and the 5 characteristic components in Maoto decoction 
 
 
a: Prescription 1, b: Prescription 2 
c: mean±S.D., n=3 
 
 
 
  Ephedrine Pseudoephedrine Paeoniflorin Puerarin Glycyrrhizic acid Cinnamic acid Cinnamaldehyde 6-Gingerol 
 Content 
(mg) 
RSD 
(%) 
Content 
(mg) 
RSD
(%)
Content 
(mg) 
RSD
(%)
Content 
(mg) 
RSD 
(%) 
Content 
(mg) 
RSD
(%)
Content 
(mg) 
RSD
(%)
Content 
(μl) 
RSD
(%)
Content 
(mg) 
RSD 
(%) 
Kakkonto Lot Aa 13.43±0.08C 0.58 5.24±0.04 0.72 59.96±0.34 0.57 72.52±0.59 0.81 35.54±0.18 0.50 2.09±0.02 0.83 17.70±0.10 0.55 3.96±0.04 1.13 
Lot Ba 15.35±0.31 2.01 18.28±0.08 0.46 46.62±0.27 0.58 63.91±0.39 0.61 37.12±0.25 0.67 1.79±0.03 1.54 15.82±0.22 1.37 2.66±0.05 1.95 
Lot Ca 14.11±0.06 0.44 5.55±0.07 1.33 45.02±0.41 0.90 81.19±0.94 1.15 43.86±0.27 0.62 2.19±0.03 1.26 19.97±0.34 1.68 5.38±0.06 1.04 
Lot Ab 22.69±0.04 0.19 9.67±0.19 1.92 77.72±0.14 0.18 150.19±0.71 0.47 32.82±0.05 0.14 2.87±0.02 0.74 17.51±0.17 0.97 2.42±0.02 1.02 
Maoto Lot D 22.26±0.03 0.13 10.45±0.01 0.12 — — — — 30.40±0.19 0.62 4.59±0.04 0.77 49.30±0.53 1.08 — — 
Lot E 29.97±0.41 1.37 33.66±0.18 0.53 — — — — 27.41±0.31 1.14 3.21±0.02 0.55 41.25±0.12 0.29 — — 
Lot F 22.16±0.09 0.42 9.06±0.09 1.01 — — — — 34.81±0.25 0.72 4.44±0.06 1.28 42.48±0.43 1.02 — — 
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2.4  Discussion 
 
About this new HPLC-DAD method, the preparation of decoction samples by 
only dilution and filtration of the decoction saves time, simplifies the process of 
sample preparation, decreases the loss of target components and makes the 
results more accurate. The analysis using a conventional HPLC column eluted 
with usual solutions makes this method easy to implement. 
With this new method, the 8 components were completely quantified within 
83 min that seems to be long. It is because that to keep the sample preparation 
simple and to decrease loss of target components, we didn’t extract the 
decoction with any organic solvent; it makes a great variety of components 
remain in the sample and the separation on the column is much more complex.   
However, we saved the time on sample preparation, and quantified the 8 
characteristic components simultaneously by one injection; actually, the total 
time of sample preparation and analysis is short.  
Moreover, comparing with the previous analytical methods with which 
researchers had to analyze the several components one by one or divide them to 
some batches, change and equilibrate the mobile phase repeatedly, this new 
analytical method is very convenient and time-saving. 
Kakkonto with different daily doses and lot numbers were quantified by this 
new method. Maoto which contains some of same crude drugs with Kakkonto 
was also quantified by this new method successfully. This method can be widely 
used for quantification of Kakkonto and other traditional medicinal formulas, 
which contain the same crude drugs or characteristic components studied in this 
part.  
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2.5  Conclusions 
 
In this part, a simple, efficient and reliable HPLC-DAD method for the 
simultaneous quantification of ephedrine, pseudoephedrine, paeoniflorin, 
puerarin, glycyrrhizic acid, cinnamic acid, cinnamaldehyde and 6-gingerol in 
Kakkonto decoction was successfully developed and validated for the first time. 
 
This method will be used in the further study, the availability research of 
decocting Kakkonto with a microwave oven. Also it can be applied for the 
quantitative determination of major characteristic components and for the 
quality control of Kakkonto decoction. In addition, this method may be used for 
other traditional medicinal formulas which contain the same crude drugs or 
characteristic components studied in this part.  
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3. Optimization of decocting conditions of the new decocting method for 
Kakkonto 
 
3.1  Materials and Methods  
 
3.1.1 Materials 
Crude drugs: Pueraria Root (Pueraria lobata Ohwi), Ephedra Herb (Ephedra 
sinica Stapf), Jujube (Zizyphus jujube Miller var. inermis Rehder), Cinnamon 
Bark (Cinnamomum cassia Blume), Peony Root (Paeonia lactiflora Pallas), 
Glycyrrhiza (Glycyrrhiza uralensis Fisher) and Ginger (Zingiber officinale 
Roscoe). 
Kakkonto[21]: Pueraria Root 4 g (Lot No. 001711004), Ephedra Herb 3 g (Lot 
No. 011711002), Jujube 3 g (Lot No. 007111015), Cinnamon Bark 2 g (Lot No. 
002811022), Peony Root 2 g (Lot No. 005311009), Glycyrrhiza 2 g (Lot No. 
002011005) and Ginger 2 g (Lot No. 005811002) were purchased from 
Tochimoto Tenkaido (Osaka, Japan). 
The standard compounds paeoniflorin, puerarin, glycyrrhizic acid, cinnamic 
acid, cinnamaldehyde and 6-gingerol were purchased from Wako Pure 
Chemical Industries, Ltd. (Tokyo, Japan). The standard compounds ephedrine 
hydrochloride and pseudoephedrine hydrochloride were purchased from Zelang, 
China. Acetonitrile (HPLC grade) was from Sigma-Aldrich (Tokyo, Japan). 
Methanol (HPLC grade) and phosphoric acid were from Wako. Distilled water 
was prepared by the purification system of Millipore. Tap water (pH 7.2, Ca2+: 
24.7 mg/L, Mg2+: 6.3 mg/L, measured with a polarized Zeeman atomic 
absorption spectrometer, Z-5300, Hitachi, Japan) was used to prepare decoction. 
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3.1.2 Instruments and chromatographic conditions 
 
A MRO-JV200 microwave oven (Hitachi, Japan) and XCK-1000 teapot 
(Hario Glass, Japan) were used in the new decocting method (Fig. 2), and an 
HMJ3-1000W electric decocting device (Hario Glass, Japan) was used in the 
conventional decocting method (Fig. 3).  
 
3.1.3 Preparation of Kakkonto decoction sample 
 
Conventional decocting method: Kakkonto (daily dose) was decocted with 
the electric decocting device in 500 ml tap water at 600 W for 40 min followed 
by the filtration through gauze. The volume of decoction was adjusted to 600 ml 
with tap water after cooling down to room temperature. The decoction was then 
filtrated through a filter paper under reduced pressure; the subsequent filtrate 
was retained and filtrated through a 0.45 μm syringe membrane filter before 
injection. 
 
New decocting method: Kakkonto (daily dose) was decocted with the 
microwave oven and teapot at 500 W. Water volume from 500 ml to 700 ml and 
decocting time from 20 min to 40 min were tested by Central Composite Design 
(CCD) of Response Surface Method (RSM). The following preparation after 
decocting was same as conventional decocting method. 
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Fig. 2  Decocting devices for the new decocting method 
 
 
 
 
 
Fig. 3  Decocting device for the conventional decocting method 
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3.1.4 Optimization methods 
 
The optimization of decocting conditions was performed with Design Expert 
software. CCD was used to optimize water volume (from 500 ml to 700 ml) and 
total decocting time (from 20 min to 40 min). Cinnamaldehyde in Cinnamon 
Bark is a volatile component, so Cinnamon Bark was put into the teapot after 
other herbal medicines have been decocted for some time to decrease the 
volatilization loss. The decocting time of Cinnamon Bark was optimized from 1 
to 15 min with One Factor Design of RSM. 
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3.2  Results and Discussion 
 
3.2.1 Decocting Kakkonto with the conventional decocting method 
  Kakkonto was decocted with the conventional decocting method mentioned 
in “3.1.3” in this chapter. Content of 8 characteristic components is shown in 
Fig. 4. These data were regarded as goals in optimization of decocting 
conditions of the new decocting method for Kakkonto.  
 
3.2.2 Optimization of water volume and total decocting time of Kakkonto 
using CCD 
According to the results of optimization experiments, we found the 
volatilization loss of cinnamaldehyde was serious (Fig. 5) and the content after 
decocting for 20 min is lower than it in the final decoction obtained by the 
conventional method (17.54 μl). Therefore, we decided to put Cinnamon Bark 
into the teapot after other herbal medicines have been decocted for some time to 
decrease the volatilization loss and optimized the decocting time of Cinnamon 
Bark with One Factor Design of RSM. Regarding component content (except 
for cinnamic acid and cinnamaldehyde in Cinnamon Bark) as the index, water 
volume and total decocting time were optimized with CCD of RSM. The 
decocting conditions under which almost the same extraction effect to the 
conventional method can be obtained were water volume-700 ml and total 
decocting time-35 min. The fitted equations and p-values of ANOVA for 
response surface models are shown in Table 4, and the response surface is 
shown in Fig. 6. 
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3.2.3 Optimization of decocting time of Cinnamon Bark using One Factor 
Design 
 
  Since the volatilization loss of cinnamaldehyde was serious, we decided to 
put Cinnamon Bark into the teapot after other herbal medicines have been 
decocted for some time to decrease the volatilization loss and optimized the 
decocting time of Cinnamon Bark from 1min to 15 min with One Factor Design 
of RSM. The decocting time of Cinnamon Bark for which almost the same 
extraction effects of cinnamic acid and cinnamaldehyde to the conventional 
method can be obtained was 8 min. The fitted equations and p-values of 
ANOVA for response surface models are shown in Table 5, and the response 
curve is shown in Fig. 7. 
 
3.2.4 Decocting Kakkonto under optimal decocting conditions 
 
According to the results of optimization, we determined decocting conditions 
of the new method as written in Table 6. Content of 8 components is shown in 
Fig. 8. Under the optimal conditions, we can get almost the same extraction 
effect to the conventional decocting method.   
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3.3  Conclusions 
 
In this chapter, a simple, efficient and reliable HPLC-DAD method for the 
simultaneous quantification of ephedrine, pseudoephedrine, paeoniflorin, 
puerarin, glycyrrhizic acid, cinnamic acid, cinnamaldehyde and 6-gingerol in 
Kakkonto decoction was successfully developed and validated. The decocting 
conditions of the new decocting method were optimized with RSMs. With this 
new method, 35 min of total decocting time was cost for Kakkonto to get almost 
the same extraction effect to the conventional decocting method which cost 40 
min; 5 min of decocting time was shortened. In a word, the new decocting 
method is as available as the conventional decocting method and time-saving.  
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          Fig. 4  Content of 8 characteristic components in Kakkonto decocted with the conventional decocting method 
(Data represent mean±S.D., n=6)  
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    Fig. 5  Cinnamaldehyde content in Kakkonto decocted with the new decocting method 
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Table 4  Fitted equations and p-values of ANOVA for response surface models for 6 components in Kakkonto decoction 
 
   Response                         Fitted equation p-Value 
Ephedrine Y=-2.33069-0.014237A+0.89132B+3.3×10-4AB+1.2138×10-5A2-0.014539B2 0.0016 
Pseudoephedrine  Y= -0.55546+4.51×10-3A+0.1091B 0.0030 
Puerarin  Y= 25.61285+0.03667A+0.5107B 0.1466 
Paeoniflorin  Y=-50.70703+0.18493A+1.40138B+2.46×10-3AB -1.66479×10-4A2-0.04008B2 0.0019 
Glycyrrhizic acid Y= 19.935+0.02405A-0.0489B 0.2728 
6-Gingerol Y= -3.56245+0.013822A+0.18029B+2.025×10-4AB-1.2631×10-5A2-5.0731×10-3B2 0.0001 
 
Y: Content in daily dose of Kakkonto decoction (mg) 
A: Water volume (ml) 
B: Total decocting time (min) 
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Fig. 6  The response surface for the effect of water volume and total decocting 
time on content of characteristic components except for cinnamic acid 
and cinnamaldehyde 
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Table 5  Fitted equations and p-values of ANOVA for response curve models 
of 2 components in Cinnamon Bark in Kakonto decoction 
 
    Response          Fitted equation p-Value 
 Cinnamic acid  Y= 1.32807+0.29110A-0.013634A2 0.0341 
 Cinnamaldehyde Y= 5.05067+2.65738A-0.14383A2 0.0040 
 
Y: Content in daily dose of Kakkonto decoction (mg for cinnamic acid, μl for cinnamaldehyde) 
A: Decocting time of Cinnamon Bark (min) 
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Fig. 7  The response curve for the effect of decocting time of Cinnamon Bark 
on content of cinnamic acid and cinnamaldehyde
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Table 6  Decocting conditions for Kakkonto 
 
Decocting device Power 
(W) 
Water 
volume (ml) 
Total decocting 
time (min) 
Decocting time for 
Cinnamon Bark (min) 
Microwave oven & teapot a 500 700 35 8c 
Electric decocting device b 600 500 40 40 
 
a: New decocting method, b: Conventional decocting method 
c: Put Cinnamon Bark into the teapot after other medicines were decocted for 27 min.  
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    Fig. 8  Content of 8 characteristic components in Kakkonto decoction (Data represent mean±S.D., n=6)  
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1. Introduction 
 
In this part, we chose Keishikabushito as a representative formula which 
contains a toxic drug-Processed Aconite Root to study the safety of decocting 
Kampo medicines with a microwave oven.  
 
Keishikabushito is a traditional formula recorded in Shanghan Lun, a 
traditional Chinese medicinal treatise authored by Zhongjing Zhang during the 
late Eastern Han Dynasty. It has been used to treat patients suffering from wind, 
excessive sweating, dysuria, and difficulty in limbs flexion and extension since 
ancient times in Asian countries[22]. It is composed of 6 crude drugs including 
Processed Aconite Root which contains toxic components.  
 
Processed Aconite Root is used widely and largely in Asia for various diseases, 
such as collapse, syncope, rheumatic fever, painful joints, gastroenteritis, 
diarrhea, oedema, bronchial asthma, various tumors, and some endocrinal 
disorders like irregular menstruation[23]. It is prepared from the roots of certain 
species of Aconitum. The raw roots of Aconitum plants have high toxicities on 
nervous system and cardiovascular system, it can even lead to death[24]. Therefore, 
only processed detoxified ones are allowed to be administrated orally in Japan 
and China[23]. 
 
There are 3 main diester alkaloids with high toxicity in Aconitum-aconitine, 
mesaconitine and hypaconitine, and they are also active components. When 
processing or decocting, the ester bonds on C-8 of aconitine alkaloids are 
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hydrolyzed and the acetyl groups are lost to get benzoylaconine alkaloids with 
less toxicity. After the further hydrolysis of the other ester bonds on C-14, 
benzoyl groups are lost to get aconine alkaloids with little toxicity (Fig. 9[23]). 
Wada et al.[25] reported that the LD50 values of aconitine of mice were 1.8 mg/kg 
p.o., 0.31 mg/kg i.p. and 0.12 mg/kg i.v., of benzoylaconine 1500 mg/kg p.o., 70 
mg/kg i.p. and 23 mg/kg i.v., and of aconine 120 mg/kg i.v. This clearly 
demonstrates that the loss of the acetyl as well as the benzoyl group significantly 
decreases the toxicity. Though the toxicity is reduced greatly the pharmacological 
activities are kept, because the hydralysates also have activities[26]. 
 
In this section, regarding content of 6 toxic alkaloids (aconitine, mesaconitine, 
hypaconitine, benzoylaconine, benzoylmesaconine and benzoylhypaconine) as 
the index, and detoxification effect of the conventional decocting method as the 
goal, we optimized decocting conditions of Keishikabushito with Response 
Surface Method. At least, we found out the decocting conditions under which we 
can get almost the same detoxification effect to the conventional decocting 
method. The safety of this new decocting method was validated. 
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               I                                         II  
  
III 
 
I II      III  R1  R2  
  Aconitine     Benzoylaconine  Aconine  CH2CH3  OH  
  Mesaconitine     Benzoylmesaconine  Mesaconine  CH3  OH  
  Hypaconitine     Benzoylhypaconine  Hypaconine  CH3  H  
 
Fig. 9  The detoxification of diterpene alkaloids by two-step hydrolysis  
 
 
 
 
+H2O 
-CH3COOH 
+H2O 
-C6H5COOH
160-170˚C 
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2. Materials and Methods 
 
2.1  Materials 
 
Crude drugs: Cinnamon Bark (Cinnamomum cassia Blume), Jujube (Zizyphus 
jujube Miller var. inermis Rehder), Peony Root (Paeonia lactiflora Pallas), 
Glycyrrhiza (Glycyrrhiza uralensis Fisher), Ginger (Zingiber officinale Roscoe) 
and Processed Aconite Root (Aconitum carmichaeli Debeaux). 
 
Keishikabushito: Cinnamon Bark 3 g (Lot No. 002811006), Jujube 4 g (Lot No. 
007111015), Peony Root 3 g (Lot No. 005311009), Glycyrrhiza 2 g (Lot No. 
002011023), and Ginger 1 g (Lot No. 005812002) were purchased from 
Tochimoto Tenkaido (Osaka, Japan); Processed Aconite Root 1g (Lot No. 
B2L0514) was purchased from Uchida Wakanyaku (Tokyo, Japan). 
 
The standard compounds aconitine, mesaconitine, hypaconitine and 
benzoylmesaconine were purchased from Wako Pure Chemical Industries, Ltd. 
(Tokyo, Japan). The standard compounds benzoylaconine and 
benzoylhypaconine were purchased from Zelang, China. Acetonitrile (HPLC 
grade) was from Sigma-Aldrich (Tokyo, Japan). Methanol (HPLC grade), 
ammonium acetate, aqueous ammonia, 37% hydrochloric acid, diethyl ether and 
ethyl acetate were from Wako. Distilled water was prepared by the purification 
system of Millipore. Tap water (pH 7.2, Ca2+: 24.7 mg/L, Mg2+: 6.3 mg/L, 
measured with a polarized Zeeman atomic absorption spectrometer, Z-5300, 
Hitachi, Japan) was used to prepare decoction. 
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2.2 Instruments and chromatographic conditions 
The decocting instruments are same as “3.1.2” in chapter 2. The rotary 
evaporator is from Tokyo Rikakikai Co., Ltd. (Tokyo, Japan), and the refrigerated 
centrifuge (O5PR-22) is from Hitachi (Japan). 
The analysis was performed on the HPLC system (Shimadzu, Japan) consists 
of an LC20AD liquid chromatograph, SPD-M20A diode array detector (DAD), 
CTO-10ASvp column oven and CBM-20A communications bus module. The 
separation was achieved on a Zorbax Extend-C18 column (250 mm × 4.6 mm i.d., 
5 μm, Agilent, USA) at 25°C by 1 ml/min mobile phase composed of A-40 mM 
ammonium acetate buffer solution (pH 10.0, adjusted with aqueous ammonia) 
and B-acetonitrile. The gradient elution conditions are as follows (shown as the 
percentage of B): 0-10 min 22%, 10-18 min 22-24%, 18-30 min 24-30%, 30-34 
min 30-38%, 34-70 min 38-56%. The injection volume was 20 μl. The signal was 
collected at 234 nm. The data processing was achieved by LC solution software 
(Shimadzu, Japan). 
 
2.3  Preparation of standard solutions 
A stock solution of standard was prepared by accurately weighing the standard 
compounds aconitine, mesaconitine, hypaconitine, benzoylmesaconine, 
benzoylaconine and benzoylhypaconine and dissolving them in one volumetric 
flask with methanol contained 0.1% (v/v) HCl to the volume. The standard 
solutions used in this study were diluted from the stock solution of standard with 
methanol contained 0.1% (v/v) HCl and filtrated through a 0.45 μm syringe 
membrane filter before injection. 
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2.4 Preparation of Keishikabushito decoction sample 
Conventional decocting method: Keishikabushito (daily dose) was decocted 
with the electric decocting device in 500 ml tap water at 600 W for 60 min 
followed by the filtration through gauze. The volume of decoction was measured. 
And then, we measured 25 ml of the subsequent filtrate, adjusted pH to 1 with 
37% hydrochloric acid and extracted with ethyl acetate for 3 times (20 ml each 
time); the mixture was separated by centrifugation (2500 rpm, 5 min) and the 
ethyl acetate layer was discarded to remove the non-alkaloid components. Then 
the acidic aqueous solution was basified with 28% ammonia solution to pH 10 
and extracted with diethyl ether for 3 times (20 ml each time). The mixture was 
separated by centrifugation (2500 rpm, 5 min); the diethyl ether layer was kept 
and dried with a rotary evaporator. The residue was dissolved with 0.5 ml of 
methanol which contains 0.1% (v/v) HCl. The sample was filtrated through a 
0.45 μm syringe membrane filter before injection. 
New decocting method: Keishikabushito (daily dose) was decocted with a 
microwave oven and teapot at 500 W. Water volume from 700 ml to 800 ml and 
decocting time from 40 min to 60 min were tested by Central Composite Design 
(CCD) of Response Surface Method (RSM). The following preparation after 
decocting was same as conventional decocting method. 
 
2.5 Optimization method 
The optimization of water volume (from 700 ml to 800 ml) and decocting time 
(from 40 min to 60 min) for Keishikabushito was performed by CCD of RSM 
with Design Expert software.  
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3. Results and Discussion 
 
3.1 Decocting Keishikabushito with the conventional decocting method 
 
  Keishikabushito was decocted with the conventional decocting method 
mentioned in “2.4” in this chapter. Content of 6 toxic alkaloids is shown in Fig. 
10. These data were regarded as goals in optimization of decocting conditions of 
the new decocting method for Keishikabushito.  
 
3.2 Optimization of water volume and decocting time of Keishikabushito 
using CCD 
 
Regarding content of 6 toxic alkaloids as the index, water volume and 
decocting time of Keishikabushito were optimized by CCD of RSM. The 
decocting conditions under which almost the same detoxification effect to the 
conventional method can be obtained were water volume-750 ml and decocting 
time-45 min. The fitted equations and p-values of ANOVA for response surface 
models are shown in Table 7, and the response surface is shown in Fig. 11. 
 
3.3 Decocting Keishikabushito under optimal decocting conditions 
 
According to the results of optimization, we decocted Keishikabushito with the 
new method in 750 ml water at 500 W for 45 min. Content of 6 toxic alkaloids is 
shown in Fig. 12.  
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    Fig. 10  Content of 6 toxic alkaloids in Keishikabushito decocted with the conventional method 
  (Data represent mean±S.D., n=4) 
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Table 7  Fitted equations and p-values of ANOVA for response surface models of  
6 toxic components in Kewishikabushito decoction 
 
   Response                          Fitted equation p-Value 
Aconitine Y= -175.51477+0.43318A+0.48830B+2.15×10-3AB-3.53586×10-4A2-0.020140B2 0.0064 
Mesaconitine Y= 504.63141-0.66440A-8.76517B+0.012280AB 0.0463 
Hypaconitine Y= 155.03899-0.31038A-1.53681B+9.2500×10-4AB+1.78690×10-4A2+7.9172×10-3B2 0.0057 
Benzoylaconine Y= 884.26436-1.17010A-18.67033B+0.026150AB 0.0397 
Benzoylmesaconine Y= 6199.10269-8.04740A-122.40650B+0.17218AB 0.1030 
Benzoylhypaconine Y= 1487.76910-1.93403A-29.55617B+0.041490AB 0.1600 
 
Y: Content in daily dose of Keishikabushito decoction (μg) 
A: Water volume (ml) 
B: Decocting time (min) 
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Fig. 11  The response surface for the effect of water volume and decocting time 
on content of 6 toxic alkaloids 
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    Fig. 12  Content of 6 toxic alkaloids in Keishikabushito decoction (Data represent mean±S.D., n=4) 
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4. Conclusions  
 
In this chapter, we optimized the decocting conditions of the new decocting 
method for Keishikabushito with Central Composite Design of Response Surface 
Method. With this new method, 45 min was cost for Keishikabushito to get 
almost the same detoxification effect to the conventional decocting method 
which cost 60 min; 15 min of decocting time was shortened. In a word, the new 
decocting method is as safe as the conventional decocting method and 
time-saving.  
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Conclusions 
 
In this study, we improved decocting method of Kampo medicines using a 
microwave oven to shorten the decocting time and improve the convenience.  
 
To validate the availability of this new decocting method, we decocted 
Kakkonto which is the most prescribed formula in clinical treatment in Japan[1] 
with the new decocting method. We developed and validated a simple, efficient 
and reliable HPLC-DAD method for the simultaneous quantification of 
ephedrine, pseudoephedrine, paeoniflorin, puerarin, glycyrrhizic acid, cinnamic 
acid, cinnamaldehyde and 6-gingerol in Kakkonto decoction. Regarding the 
content of the 8 components as the index, extraction effect of the conventional 
decocting method as the goal, we optimized the decocting conditions of the new 
decocting method for Kakkonto with Central Composite Design and One Factor 
Design of Response Surface Methods. We found out the optimal conditions as 
“500 W, 700 ml, 35 min (Cinnamon Bark was decocted for 8 min)”. Under these 
conditions, we can obtain almost the same extraction effect to the conventional 
decocting method-600 W, 500 ml, 40 min; 5 min of decocting time was shortened. 
The availability of the new decocting method for Kampo medicines is validated. 
 
To validate the safety of the new decocting method, we decocted 
Keishikabushito which contains toxic components with the new decocting 
method. Regarding content of 6 toxic alkaloids (aconitine, mesaconitine, 
hypaconitine, benzoylaconine, benzoylmesaconine and benzoylhypaconine) in 
decoction as the index, detoxification effect of the conventional decocting 
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method as the goal, we optimized the decocting conditions with CCD of RSM. 
We found out the optimal conditions as “500 W, 750 ml, 45 min”. Under these 
conditions, we can obtain almost the same detoxification effect to conventional 
decocting method-600 W, 500 ml, 60 min; 15 min of decocting time was 
shortened. The safety of the new decocting method for Kampo medicines is 
validated. 
 
In conclusion, decocting traditional medicines with a microwave oven is as 
available and safe as with the conventional decocting method. It is a convenient, 
efficient, safe, time-saving and electric energy-saving decocting method for 
Kampo medicines, and may be applied widely in clinical treatment. In that case, 
more patients will benefit from Kampo decoction and individualized treatment. 
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